167 related articles for article (PubMed ID: 1303649)
21. Serial measurement of urinary VMA and HVA levels from one infant: a study for neuroblastoma mass screening.
Sawada T; Numata K; Hirata S
J Pediatr Surg; 1992 Apr; 27(4):452-5. PubMed ID: 1522454
[TBL] [Abstract][Full Text] [Related]
22. Neuroblastoma: the case for screening infants in North America.
Woods WG; Tuchman M
Pediatrics; 1987 Jun; 79(6):869-73. PubMed ID: 3588142
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
Scriver CR; Gregory D; Bernstein M; Clow CL; Weisdorf T; Dougherty GE; Auray-Blais C; Giguère R; Lemieux B; Laberge C
CMAJ; 1987 May; 136(9):952-6. PubMed ID: 3105859
[TBL] [Abstract][Full Text] [Related]
24. Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yamashiro K; Takasugi N; Hanai J; Kawai T
Eur J Pediatr; 1990 Sep; 149(12):859-61. PubMed ID: 2226572
[TBL] [Abstract][Full Text] [Related]
25. Screening for neuroblastoma in North America. 2-year results from the Quebec Project.
Woods WG; Tuchman M; Bernstein ML; Leclerc JM; Brisson L; Look T; Brodeur GM; Shimada H; Hann HL; Robison LL
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):312-9. PubMed ID: 1456396
[TBL] [Abstract][Full Text] [Related]
26. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
Sawada T
Pediatr Hematol Oncol; 1997; 14(4):291-3. PubMed ID: 9211532
[No Abstract] [Full Text] [Related]
27. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
[TBL] [Abstract][Full Text] [Related]
28. Determination of urinary homovanillic and vanillylmandelic acids from dried filter paper samples: assessment of potential methods for neuroblastoma screening.
Tuchman M; Auray-Blais C; Ramnaraine ML; Neglia J; Krivit W; Lemieux B
Clin Biochem; 1987 Jun; 20(3):173-7. PubMed ID: 3652438
[TBL] [Abstract][Full Text] [Related]
29. [Early neuroblastoma detection in Germany. On the status of the Hamburg-Stuttgart cooperative pilot study].
Schilling FH; Erttmann R; Dohrmann S; Erb N; Winkler K; Gross U; Treuner J
Klin Padiatr; 1992; 204(4):282-7. PubMed ID: 1518266
[TBL] [Abstract][Full Text] [Related]
30. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
31. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma screening: the Canadian experience.
Lemieux B; Auray-Blais C; Giguère R; Scriver CR
Med Pediatr Oncol; 1989; 17(5):379-81. PubMed ID: 2796854
[No Abstract] [Full Text] [Related]
33. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
Berthold F; Baillot A; Hero B; Schurr P; Nerenz A; Hunneman DH; Sander J
J Clin Oncol; 1999 Apr; 17(4):1200. PubMed ID: 10561179
[TBL] [Abstract][Full Text] [Related]
34. Japanese experience of screening.
Takeda T; Hatae Y; Nakadate H; Nishi M; Hanai J; Sato Y; Takasugi N
Med Pediatr Oncol; 1989; 17(5):368-72. PubMed ID: 2796852
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of vanillylmandelic acid, homovanillic acid and creatinine in urine by reversed-phase ion-pair chromatography.
Tokuda T; Tokieda T; Anazawa A; Yoshioka M
J Chromatogr; 1990 Sep; 530(2):418-23. PubMed ID: 2079515
[No Abstract] [Full Text] [Related]
36. Mass screening for neuroblastoma in infants.
Wei M; Ye M; Dong K; Dong R
Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of the usefulness of screening for neuroblastoma.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
[TBL] [Abstract][Full Text] [Related]
38. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
Mathieu P; Philip T; Greffe J; Montegue A; Lacroix C
Clin Chim Acta; 1993 Nov; 220(2):229-32. PubMed ID: 8111967
[No Abstract] [Full Text] [Related]
39. Mass-screening of neuroblastoma using urine from infants by high-performance liquid chromatographic method: results of first (6th month) and second (14th month) screening.
Takeda T; Shimada M; Nishi M; Hanai J; Kikuchi Y
J Neurooncol; 1997 Jan; 31(1-2):165-70. PubMed ID: 9049845
[TBL] [Abstract][Full Text] [Related]
40. Mass screening of neuroblastoma in infancy.
Sawada T; Todo S; Fujita K; Iino S; Imashuku S; Kusunoki T
Am J Dis Child; 1982 Aug; 136(8):710-2. PubMed ID: 6808827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]